Investor Presentation for the quarter and half year ended September 30, 2026

October 23, 2026 To, To, National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, BKC P.J. Towers, Bandra-Kurla Complex, 25th Floor, Dalal Street, Fort Bandra (East), Mumbai-400 051 Mumbai 400 001 Symbol: JLHL Code: 543980 Subject: Investor Presentation for the quarter and half year ended September 30, 2026. Reference: Unaudited Financial Results for the quarter and half year ended on September 30, 2026 (Standalone and Consolidated) of the Company. Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time, please find the enclosed investor presentation for the Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30, 2026. The same will be available on the website of the Company at www.jupiterhospital.com You are requested to kindly take the afore mentioned on record and oblige. Thanking you, For JUPITER LIFE LINE HOSPITALS LIMITED Suma Upparatti Company Secretary & Compliance Officer CARE THAT Trusted. Tested. MOVES FORWARD, Transforming. EVERY YEAR. Investor Presentation July 2026 Investor Presentation: October 2026 (Q2 & H1FY27) Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Jupiter Life Line Hospitals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. This presentation contains certain forward looking statements concerning the Company’s future business prospects and business profitability, which are subject to a number of risks and uncertainties and the actual results could materially differ from those in such forward looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, competition (both domestic and international), economic growth in India and abroad, ability to attract and retain highly skilled professionals, time and cost over runs on contracts, our ability to manage our international operations, government policies and actions regulations, interest and other fiscal costs generally prevailing in the economy. The Company does not undertake to make any announcement in case any of these forward looking statements become materially incorrect in future or update any forward looking statements made from time to time by or on behalf of the Company. Management Commentary P a t i e n t F i r s t “I am pleased to share that, following successful negotiations with the landowner, the Board has approved the acquisition of the land currently leased for our Pune South hospital. The land measures 11,452.07 sq. m. and the total consideration is Rs 150 cr. The Rs 50 cr deposit paid earlier will be adjusted against this, so the incremental cash outflow is limited to Rs 100 cr. Owning the land removes long-term lease risk and strengthens our asset base at one of our key growth locations. Construction at Pune South is progressing well and remains on schedule. The Mira Road and BKC projects are currently in the regulatory approval and planning stages. Our Dombivli hospital saw a higher infectious-disease burden this quarter, which drove Dr. Ankit Thakker higher occupancy compared with the previous quarter. This helped narrow its EBITDA loss to Rs 0.2 cr for the period. Our other three hospitals continued to perform in line with MD & CEO expectations.” Q2FY27 Performance Highlights Rs in Cr Total Income EBITDA PBT PAT 57.4 56.4 106.9 74.2 75.1 456.5 411.0 92.2 393.6 79.3 37.5 50.6 358.5 320.0 309.8 67.0 72.6 77.8 16.8 18.4 20.2 Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 IPD OPD Others • EBITDA impact on account of the new Dombivli hospital was only Rs. 0.2 cr (due to higher medical admissions) in Q2FY27 vs Rs. 9.5 cr in Q1FY27. H1FY27 Performance Highlights Rs in Cr Total Income EBITDA PBT PAT 186.2 136.0 101.4 867.5 170.7 125.7 93.9 746.6 678.5 584.6 150.3 130.1 31.9 38.7 H1FY26 H1FY27 H1FY26 H1FY27 H1FY26 H1FY27 H1FY26 H1FY27 IPD OPD Others • EBITDA impacted by initial ramp-up losses at Dombivli Hospital of Rs. 9.7 cr in H1FY27 along with higher marketing costs related to launch activities • Higher depreciation following commercialisation of Dombivli hospital • Higher finance costs owing to an increase debt drawdown for ongoing capex H1FY27 Operating Metrics Operational Bed Capacity(1) Average Occupancy Rate(2) IPD & OPD Volumes (‘000)(3) Excluding 64.8% Census Beds Non - Census Beds Dombivli 62.2% 59.5% Hospital 614.5 1,259 538.9 30.4 1,061 IPD 27.4 1,063 929 OPD 511.5 584.1 132 196 H1FY26 H1FY27 H1FY26 H1FY27 H1FY26 H1FY27 Payor Mix ARPOB(4) IP ARPOB (5) ALOS (in Days)(6) Government Schemes Self Payors Insurance Companies 71,800 58,700 66,100 53,800 3.84 3.79 1.3% 1.0% 43.2% 44.2% 55.5% 54.8% H1FY26 H1FY27 H1FY26 H1FY27 H1FY26 H1FY27 H1FY26 H1FY27 ARPOB and IP ARPOB rounded off to the nearest hundred 1) Operational beds includes census beds (bed available for mid-night occupancy such as intensive care units (“ICUs”), wards etc.) and non-census beds (all other bed available other than census beds, such as day-care beds, casualty beds etc.) (2) Average occupancy rate is calculated as census occupied bed days (i.e. midnight census of occupied census beds during the period) divided by available census bed days (i.e. census bed capacity multiplied by the applicable days in the relevant period) (3) Out-patient volume refers to the total number of Out- patient bills generated in a specific period. Inpatient volume refers to the total number of inpatient discharge in a specific period irrespective of admission date. (4) ARPOB is calculated as income from hospital services divided by census occupied bed days (i.e. midnight census of occupied census beds during the period) (5) Calculated on Inpatient Revenue divided by Inpatient occupied bed days (excluding daycare) (6) ALOS is the average length of stay of patients in a specific period, calculated as census occupied bed days (i.e. midnight census of occupied 6 census beds during the period) divided by inpatient volume. Consolidated Profit & Loss Statement Particulars (in Rs. Crs) Q2FY27 Q2FY26 YoY Q1FY27 QoQ H1FY27 H1FY26 YoY FY26 Revenuefrom Operations 436.3 376.8 15.8% 392.6 11.1% 828.8 714.7 16.0% 1,435.6 Other Income - Operational 20.2 16.8 18.4 38.7 31.9 64.2 Total Income 456.5 393.6 16.0% 411.0 11.1% 867.5 746.6 16.2% 1,499.8 Cost of Goods Sold 86.5 73.8 80.0 166.5 144.5 287.3 Gross Profit 370.0 319.8 15.7% 331.0 11.8% 701.0 602.1 16.4% 1,212.5 Gross Profit Margin 81.1% 81.3% 80.5% 80.8% 80.6% 80.8% • EBITDA includes an operational loss from Dombivli Hospital for Rs 0.2 cr Employee Cost 81.3 63.2 74.5 155.8 125.0 256.3 and Rs 9.5 cr for Q2FY27 and Q1FY27 Professional Fees 110.2 103.0 102.2 212.4 185.7 364.0 respectively and Rs 9.7 cr in H1FY27 Other Expenses 71.6 61.4 75.0 146.6 120.8 248.9 during the initial ramp-up phase EBITDA 106.9 92.2 15.9% 79.3 34.8% 186.2 170.7 9 [Showing first 8,000 characters — download PDF for full document]